Aug 7 (Reuters) - Cartesian Therapeutics Inc RNAC.O:
CARTESIAN THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
CARTESIAN THERAPEUTICS INC - Q2 NET INCOME $15.9 MILLION, EPS $0.51
Source text: ID:nGNX1fg2nw
Further company coverage: RNAC.O
((Reuters.Briefs@thomsonreuters.com;))